Literature DB >> 3694225

Hypokalemic periodic paralysis with unusual responses to acetazolamide and sympathomimetics.

B A Vern1, M J Danon, K Hanlon.   

Abstract

Five members in three generations of a family were affected by an illness that had many clinical features of the hypokalemic form of periodic paralysis (HPP). The serum potassium was either moderately reduced or normal during attacks, and there was no evidence of myotonia or cold-intolerance. All of the patients improved to a variable degree with oral potassium supplements, and 3 responded favorably to triamterene. The usually beneficial drug acetazolamide, however, invariably caused weakness in these patients, an effect previously described in only one other family with HPP. In addition, amphetamine-like sympathomimetic drugs effectively aborted or prevented paralysis in several members. Muscle biopsy in two patients revealed some unusual features, and electromyography showed myopathic potentials. There was no evidence of diabetes. The urine electrolyte concentrations during glucose tolerance tests, however, were different from those previously reported in HPP. This family may represent a variant form of HPP.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3694225     DOI: 10.1016/0022-510x(87)90093-1

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  2 in total

1.  A Korean family of hypokalemic periodic paralysis with mutation in a voltage-gated calcium channel (R1239G).

Authors:  June Bum Kim; Kyung Yil Lee; Jae Kyun Hur
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

2.  An atypical phenotype of hypokalemic periodic paralysis caused by a mutation in the sodium channel gene SCN4A.

Authors:  Yang Hee Park; June Bum Kim
Journal:  Korean J Pediatr       Date:  2010-10-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.